LGL Group (NYSEAMERICAN:LGL) Share Price Crosses Above 200 Day Moving Average – Here’s Why

LGL Group, Inc. (The) (NYSEAMERICAN:LGL – Get Free Report)’s share price crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $7.11 and traded as high as $7.55. LGL Group shares last traded at $7.20, with a volume of 42,357 shares trading hands.

LGL Group Stock Down 1.6%

The stock has a market cap of $87.01 million, a price-to-earnings ratio of -172.50 and a beta of 0.32. The company’s 50-day moving average is $7.17 and its 200-day moving average is $7.10.

Get LGL Group alerts:

LGL Group (NYSEAMERICAN:LGL – Get Free Report) last announced its quarterly earnings results on Friday, August 14th. The industrial products company reported ($0.06) EPS for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.07). LGL Group had a negative return on equity of 0.51% and a negative net margin of 5.04%.The business had revenue of $0.75 million for the quarter, compared to the consensus estimate of $0.80 million. On average, research analysts forecast that LGL Group, Inc. will post -0.04 earnings per share for the current year.

Institutional Trading of LGL Group

Several institutional investors have recently bought and sold shares of the stock. Bard Associates Inc. bought a new stake in LGL Group in the second quarter valued at $3,378,000. Cable Car Capital LP bought a new position in shares of LGL Group during the second quarter valued at $346,000. Gamco Investors INC. ET AL lifted its holdings in shares of LGL Group by 2.8% during the first quarter. Gamco Investors INC. ET AL now owns 670,781 shares of the industrial products company’s stock valued at $4,662,000 after acquiring an additional 18,305 shares during the period. BlackRock Inc. acquired a new stake in shares of LGL Group in the 2nd quarter valued at $93,000. Finally, Citadel Advisors LLC acquired a new stake in shares of LGL Group in the 3rd quarter valued at $90,000. Institutional investors and hedge funds own 30.28% of the company’s stock.

LGL Group Company Profile

(Get Free Report)

LGL Group Inc is a United States–based company specializing in the development and commercialization of digital pathology and molecular imaging systems for research and clinical laboratories. The company’s core focus lies in enabling high-resolution visualization and quantitative analysis of tissue samples, helping scientists and pathologists accelerate biomarker discovery and diagnostic workflows. LGL Group’s platform combines advanced optics, automated slide scanning and image analysis software to deliver end-to-end solutions tailored to oncology, immunology and neuroscience research.

The company’s flagship offerings include whole-slide scanners capable of rapid, high-throughput scanning at resolutions suited for detailed morphometric and fluorescence studies.

Recommended Stories

• Five stocks we like better than LGL Group
• AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
• Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
• 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
• Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle

Receive News & Ratings for LGL Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LGL Group and related companies with MarketBeat.com's FREE daily email newsletter.